LGALS9 and neoplasm: LGALS9 mRNA, upregulated 16.5-fold in tumor tissue, produces Galectin-9 protein that interacts with tumors independently to influence tumor progression, functioning as an immune checkpoint and merging as a target for immunotherapy [70].